Difficulty: Medium
Average Score: 74%
Practice
A member of an investigational drug study team is working with healthy volunteers whose participation will help determine the optimal dosage range and pharmacokinetics of the drug. In what type of study is the team member participating?
Correct answer
A
Rationale
Phase I tests dosage and pharmacokinetics in healthy volunteers (e.g., 20-100 subjects), per Health Canada. Phase II assesses efficacy in patients. Phase III confirms benefits/risks in larger groups. Phase IV is post-market. Phase I establishes safety (e.g., NEJM, 90% proceed), making A the correct stage over B, C, or D's patient focus.